Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Biomay AG
DescriptionRecombinant peptide-carrier fusion protein vaccine against birch pollen allergy
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPreclinical
Standard IndicationAllergy
Indication DetailsTreat birch allergy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today